 |
 Previous Article | Next Article 
The Journal of Neuroscience, January 15, 2001, 21(2):363-371
Nerve Growth Factor Antiserum Induces Axotomy-Like Changes in
Neuropeptide Expression in Intact Sympathetic and Sensory Neurons
Annette M.
Shadiack,
Yi
Sun, and
Richard E.
Zigmond
Department of Neurosciences, School of Medicine, Case Western
Reserve University, Cleveland, Ohio 44106-4975
Axonal transection of adult sympathetic and sensory neurons leads
to a decrease in their content of target-derived nerve growth factor
(NGF) and to dramatic changes in the expression of several neuropeptides and enzymes involved in transmitter biosynthesis. For
example, axotomy of sympathetic neurons in the superior cervical ganglion (SCG) dramatically increases levels of galanin, vasoactive intestinal peptide (VIP), and substance P and their respective mRNAs
and decreases mRNA levels for neuropeptide Y (NPY) and tyrosine hydroxylase (TH). Axotomy of sensory neurons in lumbar dorsal root
ganglia (DRG) increases protein and mRNA levels for galanin and VIP and
decreases levels for substance P and calcitonin gene-related peptide
(CGRP). To assess whether reduction in the availability of endogenous
NGF might play an important role in triggering these changes, we
injected nonoperated animals with an antiserum against NGF ( NGF).
NGF increased levels of peptide and mRNA for galanin and VIP in
neurons in both the SCG and DRG. NPY protein and mRNA were decreased in
the SCG, but levels of TH protein and mRNA remained unchanged. In
sensory neurons the levels of SP and CGRP protein decreased after
NGF treatment. These data suggest that the reduction in levels of
NGF in sympathetic and sensory neurons after axotomy is partly
responsible for the subsequent changes in neuropeptide expression.
Thus, the peptide phenotype of these axotomized neurons is regulated
both by the induction of an "injury factor," leukemia inhibitory
factor, as shown previously, and by the reduction in a target-derived
growth factor.
Key words:
axotomy; calcitonin gene-related peptide; dorsal root
ganglion; galanin; leukemia inhibitory factor; NGF; neuropeptide Y; sensory neurons; substance P; superior cervical ganglion; sympathetic
neurons; tyrosine hydroxylase; vasoactive intestinal peptide
Copyright © 2001 Society for Neuroscience 0270-6474/01/212363-09$05.00/0
This article has been cited by other articles:
|
|
|
|
 
S. Kiryu-Seo, R. Kato, T. Ogawa, S. Nakagomi, K. Nagata, and H. Kiyama
Neuronal Injury-inducible Gene Is Synergistically Regulated by ATF3, c-Jun, and STAT3 through the Interaction with Sp1 in Damaged Neurons
J. Biol. Chem.,
March 14, 2008;
283(11):
6988 - 6996.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Bacon, N. C. H. Kerr, F. E. Holmes, K. Gaston, and D. Wynick
Characterization of an Enhancer Region of the Galanin Gene That Directs Expression to the Dorsal Root Ganglion and Confers Responsiveness to Axotomy
J. Neurosci.,
June 13, 2007;
27(24):
6573 - 6580.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Deguchi, T. Yabuuchi, R. Ando, H. Ichikawa, T. Sugimoto, and T. Takano-Yamamoto
Increase of Galanin in Trigeminal Ganglion during Tooth Movement.
J. Dent. Res.,
July 1, 2006;
85(7):
658 - 663.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Jiang, J. R. Nyengaard, J. S. Zhang, and J. Jakobsen
Selective Loss of Calcitonin Gene-Related Peptide-Expressing Primary Sensory Neurons of the A-Cell Phenotype in Early Experimental Diabetes
Diabetes,
October 1, 2004;
53(10):
2669 - 2675.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R.-R. Ji and G. Strichartz
Cell Signaling and the Genesis of Neuropathic Pain
Sci. Signal.,
September 28, 2004;
2004(252):
re14 - re14.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Ahren, G. Pacini, D. Wynick, N. Wierup, and F. Sundler
Loss-of-Function Mutation of the Galanin Gene Is Associated with Perturbed Islet Function in Mice
Endocrinology,
July 1, 2004;
145(7):
3190 - 3196.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. R. Wilfong and R. D. Dey
Nerve Growth Factor and Substance P Regulation in Nasal Sensory Neurons after Toluene Diisocyanate Exposure
Am. J. Respir. Cell Mol. Biol.,
June 1, 2004;
30(6):
793 - 800.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Li, D. Knowlton, D. M. Van Winkle, and B. A. Habecker
Infarction alters both the distribution and noradrenergic properties of cardiac sympathetic neurons
Am J Physiol Heart Circ Physiol,
June 1, 2004;
286(6):
H2229 - H2236.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Obata, H. Yamanaka, Y. Dai, T. Tachibana, T. Fukuoka, A. Tokunaga, H. Yoshikawa, and K. Noguchi
Differential Activation of Extracellular Signal-Regulated Protein Kinase in Primary Afferent Neurons Regulates Brain-Derived Neurotrophic Factor Expression after Peripheral Inflammation and Nerve Injury
J. Neurosci.,
May 15, 2003;
23(10):
4117 - 4126.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. L. Durham and A. F. Russo
Stimulation of the Calcitonin Gene-Related Peptide Enhancer by Mitogen-Activated Protein Kinases and Repression by an Antimigraine Drug in Trigeminal Ganglia Neurons
J. Neurosci.,
February 1, 2003;
23(3):
807 - 815.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Kato, S. Kiryu-Seo, and H. Kiyama
Damage-Induced Neuronal Endopeptidase (DINE/ECEL) Expression Is Regulated by Leukemia Inhibitory Factor and Deprivation of Nerve Growth Factor in Rat Sensory Ganglia after Nerve Injury
J. Neurosci.,
November 1, 2002;
22(21):
9410 - 9418.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. R. Watkins and S. F. Maier
Beyond Neurons: Evidence That Immune and Glial Cells Contribute to Pathological Pain States
Physiol Rev,
October 1, 2002;
82(4):
981 - 1011.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Dorsam and E. J. Goetzl
Vasoactive Intestinal Peptide Receptor-1 (VPAC-1) Is a Novel Gene Target of the Hemolymphopoietic Transcription Factor Ikaros
J. Biol. Chem.,
April 12, 2002;
277(16):
13488 - 13493.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
